Company: LENZ
Filing Date: 2025-03-19
Form Type: 10-K
Source: 0001815776-25-000019
Chunk: 160

Company: LENZ Therapeutics, Inc.
Filing Date: 2025-03-19
Form: 10-K
Item: Item 11
Chunk 160
---
 officers is eligible to participate in an annual cash incentive compensation program which provides participants with an opportunity to earn variable cash incentive compensation based on individual and company performance. For 2024, Mr. Schimmelpennink’s target bonus was 55% of his base salary, and Mr. Olsson’s, Dr. Odrich’s, and Mr. Chevallard's target bonus was 40% of each of his base salary.

The determination of the 2024 bonus amount was discretionary based on our board of directors assessment of company performance against corporate goals.

The actual annual cash bonuses awarded to each named executive officer for 2024 performance are set forth above in the “Bonus” column of the Summary Compensation Table for the Fiscal Year Ended December 31, 2024.

Outstanding Equity Awards at Fiscal Year-End December 31, 2024

The following table sets forth certain information regarding equity awards granted to our named executive officers that remained outstanding as of December 31, 2024. The number of shares subject to each award and, where applicable, the exercise price per share, reflect all changes as a result of our capitalization adjustments in connection with the Merger.

139

Table of Contents

Option AwardsStock AwardsNameGrant DateNumber of securities underlying unexercised options (#) exercisableNumber of securities underlying unexercised options (#) unexercisableOption exercise price ($)(1)Option expiration dateNumber of shares or units of stock that have not vested (#)Market value of shares or units of stock that have not vestedEvert Schimmelpennink3/8/2021(2)317,91124,195(3)1.04 3/7/2031—— 11/24/2022(2)77,5525,171(3)5.05 11/23/2032—— 6/20/2023(2)138,190177,674(4)6.04 6/19/2033—— 3/21/2024(5)—475,000(6)15.05 3/20/2034—— Kimberlee C. Drapkin7/28/2023(7)8,438—(7)11.94 7/27/2033—— Daniel Chevallard3/21/2024(5)—200,000(6)15.05 3/20/2034——Marc Odr